28.10.2014 Views

Annual General Meeting of the Irish Thoracic Society - IJMS | Irish ...

Annual General Meeting of the Irish Thoracic Society - IJMS | Irish ...

Annual General Meeting of the Irish Thoracic Society - IJMS | Irish ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

31<br />

1<br />

SESSION THREE ONE<br />

ANNUAL MEETING OF THE IRISH THORACIC SOCIETY • 11 - 12 November 2005 • WESTWOOD HOUSE HOTEL, GALWAY<br />

ANNUAL MEETING OF THE IRISH THORACIC SOCIETY • 11 - 12 November 2005 • WESTWOOD HOUSE HOTEL, GALWAY<br />

3<br />

SESSION<br />

SESSION THREE ONE<br />

Malignancy / Techniques<br />

3.39<br />

Hypoxic induction <strong>of</strong> proliferation in primary human<br />

lung fibroblasts: potential implications in pulmonary<br />

fibrosis<br />

Introduction<br />

Idiopathic pulmonary fibrosis (IPF) is a disease<br />

<strong>of</strong> unknown aetiology that is associated with<br />

alveolar epi<strong>the</strong>lial injury and <strong>the</strong> development <strong>of</strong><br />

fibroblast proliferation and differentiation. This<br />

leads to increased matrix deposition and ultimately<br />

severe derangement <strong>of</strong> gas exchange units. Loss <strong>of</strong><br />

alveolar function leads to impaired ventilation and<br />

potentially <strong>the</strong> development <strong>of</strong> local tissue hypoxia.<br />

Our hypo<strong>the</strong>sis is that local tissue hypoxia in <strong>the</strong><br />

lung contributes to aberrant remodelling.<br />

Results<br />

Control and patient-derived primary human lung<br />

fibroblasts and airway epi<strong>the</strong>lial cells were used to<br />

study <strong>the</strong> effect <strong>of</strong> hypoxia on proliferation. Cells<br />

were cultured in controlled oxygen environments<br />

<strong>of</strong> 1%, 3%, 5%, and 21% for various times and<br />

proliferation was measured using tritiated thymidine<br />

incorporation. Significantly increased fibroblast<br />

proliferation was seen after culture in 3% and 5%<br />

oxygen. Conditioned media from hypoxic fibroblast<br />

cultures induced proliferation in naïve cells<br />

indicating that a soluble pro-proliferative mediator<br />

may be secreted into media by fibroblasts exposed<br />

to hypoxia. Fur<strong>the</strong>rmore, conditioned media from<br />

hypoxic epi<strong>the</strong>lial cultures was also able to induce<br />

exaggerated proliferation in lung fibroblasts.<br />

Conclusions<br />

We believe that physiologically relevant hypoxic<br />

conditions induce significant increases in fibroblast<br />

proliferation and that this may have important<br />

implications in <strong>the</strong> pathogenesis <strong>of</strong> fibrotic lung<br />

disease. Ongoing studies are aimed at identifying <strong>the</strong><br />

molecular mechanisms involved in hypoxia induced<br />

fibroproliferation.<br />

AB Byrne, L Li,<br />

SC Donnelly, JA Baugh<br />

Dept <strong>of</strong> Medicine and<br />

Therapeutics, The<br />

Conway Institute for<br />

Biomolecular and<br />

Biomedical Research,<br />

University College<br />

Dublin<br />

3.41<br />

Angiosarcoma arising from <strong>the</strong> right atrium: an usual<br />

case <strong>of</strong> recurrent pulmonary embolism<br />

Introduction<br />

Angiosarcoma is an uncommon primary cardiac<br />

malignancy that usually arises from <strong>the</strong> right atrium.<br />

Clinical features are non-specific, and <strong>the</strong> tumour is<br />

frequently undiagnosed until autopsy.<br />

Method<br />

We report <strong>the</strong> case <strong>of</strong> a 37-year-old male who<br />

presented with right-sided chest pain, haemoptysis<br />

and dyspnoea.<br />

Results<br />

Pulmonary embolism was diagnosed by spiral<br />

computed tomogram (CT) scanning, however<br />

<strong>the</strong> patient failed to improve with standard<br />

anticoagulant <strong>the</strong>rapy. Repeat CT scan confirmed<br />

non-resolution <strong>of</strong> embolism and demonstrated a<br />

concomitant right atrial filling defect. Transthoracic<br />

3.42<br />

St James’ Lung Cancer Audit 2004<br />

echocardiography and magnetic resonance imaging<br />

were performed, and identified a mass lesion which<br />

extended from <strong>the</strong> free wall <strong>of</strong> <strong>the</strong> right atrium into<br />

<strong>the</strong> right main pulmonary artery. Surgical exploration<br />

confirmed extensive tumour, and radical resection<br />

was performed with right atrial reconstruction<br />

and evacuation <strong>of</strong> tumour from <strong>the</strong> pulmonary<br />

artery. Histological evaluation revealed a high-grade<br />

angiosarcoma, with positive immunohistochemial<br />

staining for CD31 and CD34. The patient was treated<br />

with adjuvant combination chemo<strong>the</strong>rapy and<br />

remains in remission at 18 months follow up.<br />

Conclusions<br />

Although <strong>the</strong> diagnosis <strong>of</strong> angiosarcoma usually<br />

portends a poor prognosis, aggressive multimodality<br />

<strong>the</strong>rapy can result in a favourable outcome.<br />

DS O’Callaghan, 1<br />

DP Breen, 1 , B Kent, 1<br />

CJ D’Adhemar, 2<br />

M Higgins, 3<br />

F O’Connell, 1 V Young 1<br />

1. CResT Directorate,<br />

2. LabMed Directorate,<br />

and<br />

3. HOPE Directorate,<br />

St James’s Hospital,<br />

Dublin<br />

3.40<br />

Congenital tracheo-oesophageal fistula: an unusual<br />

cause <strong>of</strong> recurrent RTIs in an adult<br />

Case Report<br />

A 56 year old woman presented with recurrent RTIs.<br />

She had had 5 episodes <strong>of</strong> cough with purulent<br />

sputum, fever and dull R pleuritic chest discomfort in<br />

<strong>the</strong> previous 18 months with less frequent episodes<br />

for many years prior to that. CXR showed dense R<br />

basal consolidation which was slow to improve with<br />

antibiotics. Bronchoscopy revealed a smooth, benignlooking<br />

tracheo-oesophageal fistula (TOF) posteriorly<br />

at <strong>the</strong> junction <strong>of</strong> <strong>the</strong> upper 2/3 and lower 1/3 <strong>of</strong> <strong>the</strong><br />

trachea. Niopam contrast swallow demonstrated<br />

pooling <strong>of</strong> contrast in <strong>the</strong> lower oesophagus, which<br />

was dilated, and extensive spillover <strong>of</strong> contrast<br />

through <strong>the</strong> fistula leading to a bronchogram <strong>of</strong> <strong>the</strong><br />

entire tracheo-bronchial tree. Bronchiectasis was<br />

noted in <strong>the</strong> R middle and lower lobes. PFTs showed<br />

mild combined restriction/airflow obstruction with<br />

mild impairment <strong>of</strong> gas transfer efficiency. After<br />

recovery from her current episode, <strong>the</strong> patient was<br />

advised to undergo surgical closure <strong>of</strong> <strong>the</strong> fistula,<br />

with consideration <strong>of</strong> R middle and lower lobectomy,<br />

but declined this advice. Three years later, she<br />

suffered a severe RTI with septicaemia, and after a<br />

prolonged ICU admission, passed away.<br />

Conclusion<br />

Congenital TOF is a rare, though easily diagnosed<br />

cause <strong>of</strong> recurrent RTIs and bronchiectasis in adults.<br />

B Kent, D O’Callaghan,<br />

D Breen, F O’Connell<br />

CResT Directorate,<br />

St James’s Hospital,<br />

Dublin<br />

Introduction<br />

Lung cancer remains <strong>the</strong> foremost cancer killer in<br />

Ireland, responsible for 20% <strong>of</strong> all cancer deaths.<br />

Although prevalence has fallen in men, recent years<br />

have seen a dramatic increase in lung cancer in<br />

women. Patients tend to present with late stage<br />

disease and stage for stage, lung cancer survival is<br />

worse than for o<strong>the</strong>r common cancers. Overall 5 year<br />

survival is less than 10%.<br />

Aim<br />

To audit lung cancer at St James’s for 2004.<br />

Method<br />

Interrogation <strong>of</strong> <strong>the</strong> St James’s lung cancer database.<br />

Results<br />

297 patients attended St James’s with lung cancer<br />

in 2004, representing a 6% increase on <strong>the</strong> previous<br />

year and almost 20% <strong>of</strong> <strong>the</strong> national lung cancer<br />

population. Gender analysis showed 60.9% male, 39.1%<br />

female (male:female ratio 1.56:1) with women tending<br />

to present younger than men. Almost 50% were<br />

tertiary referrals from outside <strong>the</strong> HSE SW area. 6.7%<br />

were never-smokers while 36.4% reported a family<br />

history <strong>of</strong> cancer. Analysis <strong>of</strong> morphology showed<br />

NSCLC 75%, SCLC 17.3%, Carcinoid 2%, Meso<strong>the</strong>lioma<br />

5.1% and unknown 0.7%. Of note, females represented<br />

37.6% <strong>of</strong> NSCLC (male:female ratio 1.7:1) but 45.1% <strong>of</strong><br />

SCLC (ratio 1.2:1). Stage analysis in NSCLC showed 30.4%<br />

had Stage I or II disease, 75% <strong>of</strong> whom had treatment<br />

with curative intent. 18.6% had stage III disease, 22%<br />

<strong>of</strong> whom had treatment with curative intent. 25%<br />

<strong>of</strong> those treated with curative intent for NSCLC had<br />

chemo<strong>the</strong>rapy as part <strong>of</strong> <strong>the</strong>ir treatment. Almost 50%<br />

<strong>of</strong> patients with SCLC had limited stage disease.<br />

Conclusions<br />

Lung cancer attendances at St James’s continue to<br />

rise with increasing proportion <strong>of</strong> females, who tend<br />

to present younger and have a greater propensity to<br />

develop SCLC. Chemo<strong>the</strong>rapy is playing an increasing<br />

role in treatment <strong>of</strong> NSCLC with curative intent.<br />

M Devlin, R Luddy,<br />

F O’Connell<br />

St James’s<br />

Multidisciplinary<br />

<strong>Thoracic</strong> Oncology<br />

Group<br />

42 IRISH JOURNAL OF MEDICAL SCIENCE • VOLUME 174 • NUMBER 4 • SUPPLEMENT 3<br />

IRISH JOURNAL OF MEDICAL SCIENCE • VOLUME 174 • NUMBER 4 • SUPPLEMENT 3 43

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!